Discussions focus on export expansion, technical collaboration, localised production and potential joint ventures in biosimilars, vaccines and APIs
Ahmedabad: Cadila Pharmaceuticals, one of India’s leading pharmaceutical enterprises, hosted Alexander Ruppel, Deputy Governor of the Krasnodar Region, Russia, at its corporate facility in Bhat-Dholka, Ahmedabad, to explore opportunities for strengthening bilateral cooperation between India and Russia in the pharmaceutical sector.
The Russian delegation met with senior executives of Cadila Pharmaceuticals to discuss collaborative growth, trade opportunities, strategic market access and international healthcare solutions. The engagement comes amid growing opportunities for India and Russia to deepen cooperation across pharmaceutical manufacturing, healthcare and related supply chains.
The discussions focused on key areas including technical exchange, export expansion and strategic market access, with both sides emphasising the importance of developing dependable healthcare supply chains to ensure uninterrupted access to essential medicines across international markets.
Dr. Sunil Kumar Singh, Assistant Vice President (Head of Representation – Russia), Cadila Pharmaceuticals, said, “We are honored to host the Russian delegation and explore deeper strategic alignment between India and Russia. This visit opens vital pathways to broaden international export footprint and address evolving global healthcare demands for both countries. We look forward to driving long-term value for patients worldwide with affordable healthcare solutions.”
Focus on Localised Production and Joint Ventures
Highlighting the broader economic and diplomatic significance of the engagement, Alexander Ruppel, Deputy Governor of the Krasnodar Region, Russia, said, “This visit marks a key milestone in reinforcing the bilateral relationship between Russia and India. India’s pharmaceutical expertise is globally recognized, and we see strong potential to explore each other’s markets.”
He further highlighted opportunities to focus on localised production and potential joint ventures in biosimilars, vaccines and active pharmaceutical ingredients (APIs), which could help unlock new market opportunities and foster sustainable healthcare innovation.
The discussions also underscored the potential for mutual investment and knowledge sharing, with both sides exploring avenues to leverage their respective capabilities and strengthen pharmaceutical cooperation.
Strengthening India-Russia Healthcare Partnership
The visit concluded on a positive note, with representatives from both sides reaffirming their commitment to pursuing actionable and long-term collaboration. The engagement reflects the potential for India and Russia to further strengthen their pharmaceutical partnership through trade, technology exchange, manufacturing capabilities and shared expertise, while contributing to more resilient healthcare supply chains and accessible healthcare solutions.